BTG4
protein-codingBTG anti-proliferation factor 4, the group of BTG/Tob family|MicroRNA protein coding host genes
Gene summary
The protein encoded by this gene is a member of the BTG/Tob family. This family has structurally related proteins that appear to have antiproliferative properties. This encoded protein can induce G1 arrest in the cell cycle. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~46.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0033564
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0021124
Submitter: Franklin by Genoox
whole-exome sequencing (WES) to identify four homozygous pathogenic variants in BTG4 that are responsible for human ZCF in four independent families. In vivo studies further demonstrated that the process of maternal mRNA decay was disrupted in the zygotes of the affected individuals. https://doi.org/10.1016/j.ajhg.2020.05.010
Inheritance Pattern: AR
Disease ID:MONDO:0033564
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0033564
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Obstetric
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BTG4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001367975.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 1 | 1 | 32 | 1 | 35 | |
| nonsense | 1 | 1 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 3 | 2 | 33 | 1 | 0 | 39 |
Highest pathogenic variant AF is 0.0000065684035
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001354904.1 | 4 | MANE Select | |
| Ensembl | ENSP00000509850.1 | 4 | MANE Select | |
| RefSeq | NP_001354903.1 | 4 | Standard | |
| RefSeq | NP_001354905.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- RNA degradation - Homo sapiens (human)
Biological Process
- cell cycle arrest
- negative regulation of cell population proliferation
- neuron differentiation
- negative regulation of mitotic cell cycle
Cellular Component
- cellular_component
- nucleus
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000356018
- Coding exons
- 5
- Length
- 44829
- Individuals with no LoFs
- 125724
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 12
- Defined
- 125736
- p
- 0.0000477
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.241 | 111 | 118 | 0.938 | 0.00000621 | 1490 |
| Missense (PolyPhen) | 39 | 39.59 | 0.9851 | 503 | ||
| Synonymous | -0.261 | 44 | 41.9 | 1.05 | 0.00000234 | 389 |
| Loss of Function | 2.15 | 3 | 10.5 | 0.285 | 4.44e-7 | 134 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.000062 | 0.000062 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Shows marked antiproliferative activity, being able to induce G(1) arrest.;
Recessive Scores
- pRec
- 0.137
Intolerance Scores
- LoFtool
- 0.307
- RVIS EVS
- -0.3
- RVIS percentile EVS
- 32.62
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.864
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |